Investors > News Releases
Mar 21, 2019
Myriad to Present 18 Studies at the 2019 Annual Clinical Genetics Meeting of the American College of Medical Genetics and Genomics
Pipeline
Mar 14, 2019
Myriad’s myPath® Melanoma Test Receives Medicare Coverage
Products
Mar 06, 2019
Myriad Announces Publication of Expanded Carrier Screen Study in Genetics in Medicine  
Products
Feb 26, 2019
Myriad’s BRACAnalysis CDx® Test Successfully Identified Patients with Metastatic Pancreatic Cancer Who Benefitted from Treatment with Olaparib
Pipeline
Feb 22, 2019
Vectra® Study Published in the Journal Current Medical Research & Opinion
Pipeline
Feb 15, 2019
Myriad Applauds the American Society of Breast Surgeons New Guidelines Recommending Genetic Testing for All People with Breast Cancer
Products
Feb 13, 2019
Myriad Genetics to Present at Multiple Upcoming Healthcare Conferences
Corporate
Feb 11, 2019
Myriad Announces Prequel™ Prenatal Screen with Expanded Aneuploidy Analysis for all 23 Chromosome Pairs
Pipeline
Feb 08, 2019
Myriad to Present New Data for Its Expanded Carrier and Noninvasive Prenatal Screens at the 2019 Society for Maternal-Fetal Medicine Annual Meeting
Pipeline
Feb 05, 2019
Myriad Genetics Reports Fiscal Second-Quarter 2019 Financial Results
Financial
Jan 28, 2019
Myriad to Announce Fiscal Second-Quarter 2019 Financial Results on February 5, 2019
Corporate
Jan 04, 2019
GeneSight® GUIDED Study Published in the Journal of Psychiatric Research
Products
Dec 31, 2018
Peter D. Meldrum (1947-2018)
Corporate
Dec 27, 2018
Myriad Genetics to Present at the 37th Annual J.P. Morgan Healthcare Conference
Corporate
Dec 26, 2018
Myriad Announces Publication of Vectra® Study in Journal Rheumatology
Products